Research Article

AKI Epidemiology and Outcomes: A Retrospective Cohort Study from the Prenephrology Era

Table 2

Distribution of epidemiological and morbidity-associated characteristics in AKIN stages I–III.

Risk factorAKIN I (n = 50)AKIN II (n = 210)AKIN III (n = 220) value

Gender (%)f: 58; m: 42f: 46.2; m: 53.8f: 41.8; m: 58.20.11
Age (mean years ± SEM)71.5 ± 2.174.5 ± 0.872.7 ± 0.90.18
DOS (mean days ± SEM)13.7 ± 1.415.3 ± 1.214.2 ± 0.80.69
Preexisting CKD (%)4668,358,60.007
AKI onset (outpatient vs. in-hospital, %)o: 54.2; i: 45.8o: 64.7; i: 35.3o: 63.8; i: 36.20.38
Dialysis due to AKI (%)00,512<0.001
Survival (%)8878,665<0.001
Renal recovery (%)3227,117,80.023
Creatinine initially (micromole/L ± SEM)124 ± 6.4169 ± 4.6329 ± 17.4<0.001
CRP initially (mg/L ± SEM)61.2 ± 11.391.5 ± 7.7100.9 ± 7.60.07
Vasopressor (%)1625,239,3<0.001
Invasive ventilation (%)1624,332,90,02
Arterial hypertension (%)8490900,42
Coronary artery disease (%)3436,730,50,39
Chronic heart failure (%)3845,238,20,29
Diabetes mellitus (%)3636,238,60,85
Obesity (%)1817,112,70,37
Neoplasia (%)1831,630,60,15

The values in bold represent statistically significant results.